April 28, 20203 min read, 578 words
Published: April 28, 2020 | 3 min read, 578 words
In this articleGilead reports 'positive data' on remdesivir coronavirus drug trialStocks jumped Wednesday on the back of positive data from a potential coronavirus treatment from Gilead Sciences, while investors digested a sharp drop in U.S. economic activity. The surged 532...
CRITIC REVIEWS
There don't seem to be any reviews yet.
PUBLIC REVIEWS
There don't seem to be any reviews yet.